
Vaxcell-Bio to launch Korea’s 1st immunotherapy for pets with mammary tumor
Vaxcell-Bio, a Korean biotech company specializing in immunotherapy, said it will officially launch Vaxlukin-15, Korea’s first pet immunotherapy, in late March. The company recently supplied the initial batch of Vaxlukin-15 to Yuhan Corp., which will …